Abstract 4880: A novel heparan-sulfate (HS) oligosaccharide on tumor-blood vessels is a target for anti-immune vascular therapy in renal cell carcinoma (RCC)
Year: 2025
Type: conference-abstract
Source: Cancer Research
Institution: The University of Texas Southwestern Medical Center
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4409634265